Related Experiment Video
Updated: Apr 30, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Amino Acid-based Coacervates with Tunable Stimulus-Responsive Properties for Enhanced Acute Colitis Therapy
Fanchen Yu1,2, Suling Zhang3, Yang Xu1
1Beijing National Laboratory for Molecular Sciences (BNLMS), CAS Key Lab of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Beijing, P. R. China.
Abstract:
Biomolecular condensates play crucial roles in cellular organization and are emerging as versatile platforms for biomedicine. However, their limited pH stability constrains functionality across diverse physiological environments. Here, we report a molecular shielding strategy to achieve tunable coacervation of simple amino acids over a wide pH range (1.0-13.0). To be specific, selective modification of terminal ionizable groups blocks pH-induced charge variations, thereby leading to phase behavior independent of environmental pH. In addition, such amino acid-based coacervates possess distinct thermoresponsive features, displaying either elastin-like lower critical solution temperature (LCST) or prion-like upper critical solution temperature (UCST) phase transitions. In particular, the programmable pH-responsive feature permits biocompatible N-terminal shielding phenylalanine coacervates to remain stable under harsh gastric conditions and prolonged gastrointestinal drug retention. As a result, highly efficient oral delivery and therapy in acute colitis are achieved in vivo. This work opens a new avenue to construct programmable coacervates responding to physiological environmental changes for biomedical applications.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Modified-Release Drug Delivery Systems: Stimuli-Activated
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

